✦ LIBER ✦

Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

✍ Scribed by Thompson, Marilyn E.; Jensen, Roy A.; Obermiller, Patrice S.; Page, David L.; Holt, Jeffrey T.

Book ID: 109915708
Publisher: Nature Publishing Group
Year: 1995
Tongue: English
Weight: 769 KB
Volume: 9
Category: Article
ISSN: 1061-4036
DOI: 10.1038/ng0495-444

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acceleration of chromosomal instability

Acceleration of chromosomal instability by loss of BRCA1 expression and p53 abnormality in sporadic breast cancers

✍ Yasuo Miyoshi; Kyoko Iwao; Yuri Takahashi; Chiyomi Egawa; Shinzaburo Noguchi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 81 KB

The ectopic expression of BRCA1 is assoc

The ectopic expression of BRCA1 is associated with genesis, progression, and prognosis of breast cancer in young patients

✍ Zhang, Qingli; Zhang, Qinghui; Cong, Hua; Zhang, Xiaoli 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 391 KB

Decreased expression of annexin A1 is co

Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis

✍ Dejun Shen; Farzad Nooraie; Yahya Elshimali; Victor Lonsberry; Jianbo He; Shikha 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 773 KB

Decreased expression of angiogenesis ant

Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker

✍ Ariane Sadr-Nabavi; Juliane Ramser; Juliane Volkmann; Joerg Naehrig; Frank Wiesm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 707 KB

## Abstract EGF‐containing fibulin‐like extracellular matrix protein 1 (EFEMP1) was recently described as an antagonist of angiogenesis. Motivated by a strong dependence of tumor growth and metastasis on angiogenesis, we investigated the role of EFEMP1 in human breast cancer. We applied RNA microar